As of 2024-12-15, the Relative Valuation of Bionano Genomics Inc (BNGO) is (43.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Bionano Genomics Inc based on Relative Valuation is -18358.0%.
The range of the Relative Valuation is (41.56) - (44.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.2x - 34.8x | 33.4x |
| Forward P/E multiples | 31.0x - 33.3x | 32.4x |
| Fair Price | (41.56) - (44.28) | (43.80) |
| Upside | -17425.7% - -18557.8% | -18358.0% |
| Date | P/E |
| 2024-12-13 | -0.18 |
| 2024-12-12 | -0.18 |
| 2024-12-11 | -0.18 |
| 2024-12-10 | -0.18 |
| 2024-12-09 | -0.19 |
| 2024-12-06 | -0.18 |
| 2024-12-05 | -0.18 |
| 2024-12-04 | -0.18 |
| 2024-12-03 | -0.18 |
| 2024-12-02 | -0.19 |
| 2024-11-29 | -0.19 |
| 2024-11-27 | -0.18 |
| 2024-11-26 | -0.18 |
| 2024-11-25 | -0.19 |
| 2024-11-22 | -0.17 |
| 2024-11-21 | -0.16 |
| 2024-11-20 | -0.16 |
| 2024-11-19 | -0.17 |
| 2024-11-18 | -0.17 |
| 2024-11-15 | -0.18 |
| 2024-11-14 | -0.19 |
| 2024-11-13 | -0.21 |
| 2024-11-12 | -0.20 |
| 2024-11-11 | -0.21 |
| 2024-11-08 | -0.21 |
| 2024-11-07 | -0.22 |
| 2024-11-06 | -0.23 |
| 2024-11-05 | -0.22 |
| 2024-11-04 | -0.21 |
| 2024-11-01 | -0.21 |
| 2024-10-31 | -0.22 |
| 2024-10-30 | -0.25 |
| 2024-10-29 | -0.24 |
| 2024-10-28 | -0.23 |
| 2024-10-25 | -0.23 |
| 2024-10-24 | -0.22 |
| 2024-10-23 | -0.22 |
| 2024-10-22 | -0.23 |
| 2024-10-21 | -0.24 |
| 2024-10-18 | -0.25 |
| 2024-10-17 | -0.24 |
| 2024-10-16 | -0.25 |
| 2024-10-15 | -0.25 |
| 2024-10-14 | -0.26 |
| 2024-10-11 | -0.28 |
| 2024-10-10 | -0.28 |
| 2024-10-09 | -0.32 |
| 2024-10-08 | -0.32 |
| 2024-10-07 | -0.33 |
| 2024-10-04 | -0.35 |